BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Diabetes mellitus
,
Lymphocyte
,
Holistic medicine
,
PPARA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cellular response to cisplatin
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Subthalamic nucleus
Skeletal muscle
Thalamus
Substantia nigra reticulata
Globus pallidum external
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Deficiency of oxygenase
Vesicular stomatitis Indiana virus disease
Myocardial ischemia
Dermatosis due to mites
Injury of external ear
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Lymphotoxin-beta
sitagliptin
PHA 665752
CP 724714
PF 3758309
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR4709
TERF2IP
PGAM1
FN1
FOXN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
Spinal cord injury and regeneration
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for cellular response to cisplatin
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors
Intratumoral Cisplatin for Resectable NSCLC
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ